Examples of using Differences were observed in English and their translations into Romanian
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
Differences were observed at each visit after 4 weeks(duloxetine 54%,
However, in study US301 no significant differences were observed between leflunomide and methotrexate in the primary efficacy parameters.
No statistical differences were observed between treatment groups for Global Quality of Life.
HIV-infected patients and no substantial differences were observed between these two groups.
Regarding the whole body reaction time, no significant differences were observed before and after the 4-week period in the case of the PW group, as seen in Figure 5B.
The pharmacokinetics of Pixuvri was dose-independent in the 3 mg/m2 to105 mg/m2 dose range and no substantial differences were observed when the medicinal product was given as a single agent or in combination studies.
in HIV-infected patients; no substantial differences were observed between the two groups.
No overall differences were observed in the safety of IONSYS fentanyl 40 micrograms in elderly patients(≥ 65 years including a subpopulation≥ 75 years)
No overall differences were observed in the safety profile of elderly patients≥ 65 years of age and younger adult patients<
No apparent differences were observed between patients treated with eptifibatide
No apparent differences were observed between patients treated with eptifibatide
fluticasone furoate nasal spray 110 micrograms once daily was effective but no significant differences were observed between fluticasone furoate nasal spray 55 micrograms once daily
In the congenital heart disease study no medically important differences were observed in ADRs by body system or when evaluated in subgroups of children by clinical category.
but no significant differences were observed in both groups.
No statistically significant differences were observed between olaparib and placebo in patient reported symptoms
no major differences were observed in the safety and effectiveness of axitinib between patients who were≥ 65 years of age
No medically important differences were observed during the prophylactic studies carried out in the premature and bronchopulmonary dysplasia paediatric
No difference was observed between leflunomide and sulphasalazine(study MN301).
However, considerable differences are observed between countries, particularly in the proportion of regular cannabis users entering treatment.
no significant difference was observed in the pharmacokinetics of Perjeta between patients< 65 years(n=306) and patients≥ 65 years(n=175).